235. 副甲状腺機能低下症 Hypoparathyroidism Clinical trials / Disease details

臨床試験数 : 88 / 薬物数 : 107 - (DrugBank : 24) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 7

9 trials found

diseases per page:

Showing 1 to 9 of 9 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2015-003108-22-GB (EUCTR)	08/12/2015	26/10/2015	Study on parathyroid hormone for use in hypoparathyroidism in children 12 to less than 18 years old. ...	An Open-label, Single-dose Study to Determine the Pharmacokinetic/Pharmacodynamic Profile of Parathy ...	Chronic hypoparathyroidism;Therapeutic area: Diseases [C] - Hormonal diseases [C19]	Product Name: Parathyroid Hormone (rDNA) Product Code: NPSP 558 INN or Proposed INN: INN Parathyroid Ho ...	NPS Pharmaceuticals, Inc.	NULL	Not Recruiting			Female: yes Male: yes	10	Phase 1	United Kingdom
2	EUCTR2011-001265-40-HU (EUCTR)	29/07/2011	23/05/2011	A Study to Assess the Effects of Parathyroid Hormone (rhPTH [1-84]), in Submjects with Hypoparathyro ...	A 6-Month Open-label Study Investigating the Safety and Tolerability of NPSP558, a Recombinant Human ...	Hypoparathyroidism MedDRA version: 13.1;Level: PT;Classification code 10021041;Term: Hypoparathyroid ...	Trade Name: PREOTACT Product Name: Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Product Code: N ...	NPS Pharmaceuticals, Inc.	NULL	Not Recruiting			Female: yes Male: yes	30		Hungary
3	EUCTR2008-005063-34-LT (EUCTR)	29/11/2010	16/08/2010	A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP 558, a ...	A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP 558, a ...	Hypoparathyroidism MedDRA version: 13.0;Level: PT;Classification code 10021041;Term:	Trade Name: PREOTACT Product Name: Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Product Code: N ...	NPS Pharmaceuticals, Inc.	NULL	Not Recruiting			Female: yes Male: yes	160	Phase 3	Hungary;United Kingdom;Belgium;Denmark;France;Italy;Lithuania
4	EUCTR2008-005063-34-HU (EUCTR)	27/09/2010	04/10/2010	A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP 558, a ...	A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP 558, a ...	Hypoparathyroidism MedDRA version: 13.1;Level: PT;Classification code 10021041;Term: Hypoparathyroid ...	Product Name: Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Product Code: NPSP 558 INN or Propos ...	NPS Pharmaceuticals, Inc.	NULL	Not Recruiting			Female: yes Male: yes	110	Phase 3	Hungary;United Kingdom;Belgium;Denmark;France;Italy;Lithuania
5	EUCTR2008-005063-34-FR (EUCTR)	14/09/2009	14/11/2008	A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP 558, a ...	A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP 558, a ...	Hypoparathyroidism MedDRA version: 9.1;Level: LLT;Classification code 10021041;Term: Hypoparathyroid ...	Product Name: Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Product Code: NPSP 558 INN or Propos ...	NPS Pharmaceuticals, Inc.	NULL	Not Recruiting			Female: yes Male: yes	84	Phase 3	France;Hungary;Belgium;Lithuania;Denmark;Italy;United Kingdom
6	EUCTR2008-005063-34-DK (EUCTR)	27/08/2009	17/11/2008	A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP 558, a ...	A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP 558, a ...	Hypoparathyroidism MedDRA version: 13.0;Level: PT;Classification code 10021041;Term:	Product Name: Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Product Code: NPSP 558 INN or Propos ...	NPS Pharmaceuticals, Inc.	NULL	Not Recruiting			Female: yes Male: yes	110	Phase 3	Hungary;United Kingdom;Belgium;Denmark;France;Italy;Lithuania
7	EUCTR2008-005063-34-GB (EUCTR)	04/08/2009	22/05/2009	A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP 558, a ...	A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP 558, a ...	Hypoparathyroidism MedDRA version: 13.0;Level: PT;Classification code 10021041;Term:	Product Name: Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Product Code: NPSP 558 INN or Propos ...	NPS Pharmaceuticals, Inc.	NULL	Not Recruiting			Female: yes Male: yes	110	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	France;Hungary;Belgium;Lithuania;Denmark;Italy;United Kingdom
8	EUCTR2008-005063-34-IT (EUCTR)	27/04/2009	18/06/2009	A Randomized, Double-blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a R ...	A Randomized, Double-blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a R ...	Hypoparatthyroidism MedDRA version: 12.0;Level: LLT;Classification code 10021041;Term: Hypoparathyro ...	Product Code: NPSP 558 Product Code: NPSP 558 Product Code: NPSP 558	NPS PHARMACEUTICALS	NULL	Not Recruiting			Female: yes Male: yes	84	Phase 3	Hungary;United Kingdom;Belgium;Denmark;France;Italy;Lithuania
9	EUCTR2008-005063-34-BE (EUCTR)	18/11/2008	18/11/2008	A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP 558, a ...	A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP 558, a ...	Hypoparathyroidism MedDRA version: 12.0;Level: PT;Classification code 10021041;Term:	Product Name: Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Product Code: NPSP 558 INN or Propos ...	NPS Pharmaceuticals, Inc.	NULL	Not Recruiting			Female: yes Male: yes	160	Phase 3	Lithuania;Denmark;Italy;United Kingdom;France;Hungary;Belgium

First Previous1Next Last